Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma
by
Yin, Ping
, Xia, Luling
in
Bioinformatics
/ biomarker
/ Biomarkers
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Bladder cancer
/ CD8 antigen
/ Cell adhesion & migration
/ Cell culture
/ Cell cycle
/ Cell Line, Tumor
/ Cell migration
/ Cell Movement
/ Cell Proliferation
/ Cloning
/ Copy number
/ Data mining
/ Datasets
/ Flow cytometry
/ Gene expression
/ Gene Expression Regulation, Neoplastic
/ Genomics
/ Humans
/ Immunology
/ Immunotherapy
/ Lymphocytes T
/ Medical prognosis
/ Melanoma
/ Melanoma - genetics
/ Melanoma - immunology
/ Melanoma - metabolism
/ Melanoma - pathology
/ Melanoma, Cutaneous Malignant
/ Metastases
/ Methyltransferase
/ Methyltransferases - genetics
/ Methyltransferases - metabolism
/ METTL1
/ Myc protein
/ Phenotypes
/ Prognosis
/ Proteins
/ RNA modification
/ SKCM
/ Skin Neoplasms - genetics
/ Skin Neoplasms - immunology
/ Skin Neoplasms - metabolism
/ Skin Neoplasms - pathology
/ Software
/ Statistical analysis
/ Stem cells
/ Therapeutic targets
/ Transfer RNA
/ Tumors
/ Up-Regulation
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma
by
Yin, Ping
, Xia, Luling
in
Bioinformatics
/ biomarker
/ Biomarkers
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Bladder cancer
/ CD8 antigen
/ Cell adhesion & migration
/ Cell culture
/ Cell cycle
/ Cell Line, Tumor
/ Cell migration
/ Cell Movement
/ Cell Proliferation
/ Cloning
/ Copy number
/ Data mining
/ Datasets
/ Flow cytometry
/ Gene expression
/ Gene Expression Regulation, Neoplastic
/ Genomics
/ Humans
/ Immunology
/ Immunotherapy
/ Lymphocytes T
/ Medical prognosis
/ Melanoma
/ Melanoma - genetics
/ Melanoma - immunology
/ Melanoma - metabolism
/ Melanoma - pathology
/ Melanoma, Cutaneous Malignant
/ Metastases
/ Methyltransferase
/ Methyltransferases - genetics
/ Methyltransferases - metabolism
/ METTL1
/ Myc protein
/ Phenotypes
/ Prognosis
/ Proteins
/ RNA modification
/ SKCM
/ Skin Neoplasms - genetics
/ Skin Neoplasms - immunology
/ Skin Neoplasms - metabolism
/ Skin Neoplasms - pathology
/ Software
/ Statistical analysis
/ Stem cells
/ Therapeutic targets
/ Transfer RNA
/ Tumors
/ Up-Regulation
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma
by
Yin, Ping
, Xia, Luling
in
Bioinformatics
/ biomarker
/ Biomarkers
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Bladder cancer
/ CD8 antigen
/ Cell adhesion & migration
/ Cell culture
/ Cell cycle
/ Cell Line, Tumor
/ Cell migration
/ Cell Movement
/ Cell Proliferation
/ Cloning
/ Copy number
/ Data mining
/ Datasets
/ Flow cytometry
/ Gene expression
/ Gene Expression Regulation, Neoplastic
/ Genomics
/ Humans
/ Immunology
/ Immunotherapy
/ Lymphocytes T
/ Medical prognosis
/ Melanoma
/ Melanoma - genetics
/ Melanoma - immunology
/ Melanoma - metabolism
/ Melanoma - pathology
/ Melanoma, Cutaneous Malignant
/ Metastases
/ Methyltransferase
/ Methyltransferases - genetics
/ Methyltransferases - metabolism
/ METTL1
/ Myc protein
/ Phenotypes
/ Prognosis
/ Proteins
/ RNA modification
/ SKCM
/ Skin Neoplasms - genetics
/ Skin Neoplasms - immunology
/ Skin Neoplasms - metabolism
/ Skin Neoplasms - pathology
/ Software
/ Statistical analysis
/ Stem cells
/ Therapeutic targets
/ Transfer RNA
/ Tumors
/ Up-Regulation
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma
Journal Article
Upregulated m7G methyltransferase METTL1 is a potential biomarker and tumor promoter in skin cutaneous melanoma
2025
Request Book From Autostore
and Choose the Collection Method
Overview
The m7G methyltransferase METTL1 has been implicated in the occurrence and progression of several cancers. However, its clinical significance in cutaneous melanoma (SKCM) remains poorly understood. To address this gap, we conducted comprehensive data mining using publicly available datasets and two single-cell datasets. Additionally, we employed CCK8 assays, clone formation assays, and cell migration and invasion experiments to validate our findings from the data mining. Our results revealed that METTL1 is significantly upregulated in SKCM and is associated with a stem cell-like phenotype. Patients with high METTL1 expression exhibited worse prognosis. Furthermore, we identified that the high expression of METTL1 in SKCM is driven by copy number amplification and regulated by the transcription factor MYC. In vitro cellular studies confirmed that METTL1 knockdown significantly inhibited SKCM cell proliferation, clone formation, migration, and invasion. Notably, we observed a strong negative correlation between METTL1 expression and CD8+ T-cell infiltration in SKCM tissues. Moreover, our analysis revealed a significant negative correlation between METTL1 expression levels and the response to immunotherapy in SKCM patients, suggesting that METTL1 may serve as a potential biomarker for predicting immunotherapy response in SKCM. In summary, this study enhances our understanding of the role of m7G RNA modification in tumor progression and highlights METTL1 as a novel therapeutic target and biomarker for SKCM immunotherapy.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Biomarkers, Tumor - genetics
/ Biomarkers, Tumor - metabolism
/ Cloning
/ Datasets
/ Gene Expression Regulation, Neoplastic
/ Genomics
/ Humans
/ Melanoma
/ Melanoma, Cutaneous Malignant
/ Methyltransferases - genetics
/ Methyltransferases - metabolism
/ METTL1
/ Proteins
/ SKCM
/ Software
/ Tumors
This website uses cookies to ensure you get the best experience on our website.